Treatment of a clinically determined lower-risk stage III non-lymphoblastic non-Hodgkin lymphoma with less intensive therapy does not impact negatively on outcome

Asim F. Belgaumi, Lobna Shalaby, Amani Al-Kofide, M. Ashraf Chaudhary, Christopher Alviedo, Rajeh Sabbah

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treatment of a clinically determined lower-risk stage III non-lymphoblastic non-Hodgkin lymphoma with less intensive therapy does not impact negatively on outcome'. Together they form a unique fingerprint.

Nursing and Health Professions

Neuroscience

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science